← All stocks

Revolution Medicines, Inc.

RVMD Scheduled selling only
CIK 0001628171 #590 in the set updated 17 Sep 2026
Bought (1 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$66.74M
$14.97M on a plan · $51.77M straight out of an exercise
Sold at will
$0.00
0 of 51 sales
Net
−$66.74M
$0.00 against sales at will

By person

17 insiders · 51 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Kelsey Stephen Michael
See Remarks
$18.72M (8) scheduled
−$18.72M
291,876
0.1362%
$60.07M
+9.8%
GOLDSMITH MARK A
See Remarks
$17.99M (18) scheduled
−$17.99M
328,754
0.1534%
$67.66M
+102.4%
Kim Lorence H.
Director
$14.97M (14) scheduled
−$14.97M
1,191
0.0006%
$245.12K
−98.3%
Cislini Jeff
General Counsel
$11.90M (6) scheduled
−$11.90M
55,907
0.0261%
$11.51M
+20.9%
Mancini Anthony
See Remarks
$3.15M (5) scheduled
−$3.15M
43,890
0.0205%
$9.03M
−19.6%
Borisy Alexis
Director
2,340,075
1.09%
$481.60M
+0.2%
Schroeder Thilo
Director
760,869
0.3550%
$156.59M
Horn Margaret A
Chief Operating Officer
154,647
0.0722%
$31.83M
+15.7%
Anders Jack
Chief Financial Officer
123,269
0.0575%
$25.37M
+23.0%
Wang Xiaolin
See Remarks
116,063
0.0541%
$23.89M
+33.9%
Wei Lin
Chief Medical Officer
101,366
0.0473%
$20.86M
−10.7%
Horning Sandra
Director
97,765
0.0456%
$20.12M
+4.6%
Borellini Flavia
Director
26,215
0.0122%
$5.40M
+19.8%
ANDERSON ELIZABETH M
Director
24,406
0.0114%
$5.02M
+21.6%
Patel Sushil
Director
21,656
0.0101%
$4.46M
+8.6%
Weber Barbara
Director
13,065
0.0061%
$2.69M
−28.5%
Clyburn Frank
Director
10,929
0.0051%
$2.25M
+57.7%

Nothing of that kind in this period.

What was left out

Form 4 filings counted 6
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 14
Sales straight out of an exercise 37
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 238,174
History held since 14 Feb 2020